UNSPSC 51401905: Panadiplon

This classification denotes an anxiolytic with the molecular formula C18H17N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V4PW0S7ZP7, chemically known as 3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-5-isopropylimidazo(1,5-a)quinoxalin-4(5h)-one but generally known as panadiplon, which bears US NIH Compound Identifier 3033821. European Medicines Agency schedules Panadiplon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09600MIG. The term PANADIPLON is an International Non-Proprietary Name.

UNSPSC 51401905 Panadiplon is a Commodity code identifying pharmaceutical products, though state and local procurement activity under this code shows minimal recent activity focused on naloxone and drug deactivation systems rather than panadiplon itself. State and local governments procuring under this taxonomy segment purchase emergency medical countermeasures and harm-reduction supplies to support public health and community safety initiatives. Issuing bodies include county health departments and public health agencies managing community health programming and opioid-response initiatives.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The solicitation required bids by July 26, 2023, included E-Verify and drug-free workplace certification requirements, and contemplated a two-year initial contract term with a one-year renewal option. The mismatch between the code's nominal pharmaceutical scope and the actual procurement signals that state and local procurement offices may tag harm-reduction and emergency medical supplies under broader pharmaceutical commodity codes rather than creating dedicated lines for specialized public health products.